Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Journal of the International AIDS Society
|
June 12, 2021
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL
Andrew Atkinson, Jose M Miro, Amanda Mocroft, et al.
The Pediatric Infectious Disease Journal
|
February 24, 2026
Body Composition Changes in Children Living With HIV Initiated on Dolutegravir or Protease Inhibitors in the CHAPAS-4 Trial
Eva Natukunda, Alex J Szubert, Mutsa Bwakura-Dangarembizi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 22, 2010
Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
, Amanda Mocroft, Peter Reiss, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 14, 2023
First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial
Hylke Waalewijn, Alexander J Szubert, Roeland E Wasmann, et al.
Plos Medicine
|
January 31, 2018
Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study
, Ali Judd, Elizabeth Chappell, et al.
The New England Journal of Medicine
|
May 14, 2025
Second-Line Antiretroviral Therapy for Children Living with HIV in Africa
Victor Musiime, Mutsa Bwakura-Dangarembizi, Alexander J Szubert, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Journal of the International AIDS Society
|
June 12, 2021
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL
Andrew Atkinson, Jose M Miro, Amanda Mocroft, et al.
The Pediatric Infectious Disease Journal
|
February 24, 2026
Body Composition Changes in Children Living With HIV Initiated on Dolutegravir or Protease Inhibitors in the CHAPAS-4 Trial
Eva Natukunda, Alex J Szubert, Mutsa Bwakura-Dangarembizi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 22, 2010
Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
, Amanda Mocroft, Peter Reiss, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 14, 2023
First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial
Hylke Waalewijn, Alexander J Szubert, Roeland E Wasmann, et al.
Plos Medicine
|
January 31, 2018
Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study
, Ali Judd, Elizabeth Chappell, et al.
The New England Journal of Medicine
|
May 14, 2025
Second-Line Antiretroviral Therapy for Children Living with HIV in Africa
Victor Musiime, Mutsa Bwakura-Dangarembizi, Alexander J Szubert, et al.
Page
of 4